活的更长、活得更好——糖尿病与“健康中国2030”
|
摘要
<正>中华人民共和国国务院于2016年10月颁发的《"健康中国2030"规划纲要》提出到2030年具体实现以下目标:至2030年我国人均预期寿命将由2015年的76. 34岁提高到79. 0岁,重大慢性病过早死亡率将在2013年19. 1%的基础上进一步降低30%。这些目标的制定是中国积极参与全球健康治理、履行2030年可持续发展议程(Sustainable Development Goals,SDGs)~([1])国际承诺的重大举措。全球流行病学数据~([2])显示,由主要慢性非传染性疾病(肿瘤、心血管疾病、糖尿病和慢性呼吸系
引文
[1]UN General Assembly.Trans forming our world:The 2030 agenda for sustainable development.2015.https://sustainabledevelopment.un.org/post2015/transformingourworld/publication.
[2]Wang H,Naghavi M,Allen C,et al.Global,regional,and national life expectancy,all-cause mortality,and cause-specific mortality for 249 causes of death,1980-2015:A systematic analysis for the global burden of disease study 2015.Lancet,2016,388:1459-1544.
[3]Cao B,Bray F,Ilbawi A,et al.Effect on longevity of onethird reduction in premature mortality from non-communicable diseases by 2030:A global analysis of the sustainable development goal health target.Lancet Glob Health,2018,6:e1288-e1296.
[4]Bragg F,Holmes MV,Iona A,et al.Association between diabetes and cause-specific mortality in rural and urban areas of China.JAMA,2017,317:280-289.
[5]Home P.Cardiovascular outcome trials of glucose-lowering medications:An update.Diabetologia,2019 Jan 3.doi:10.1007/s00125-018-4801-1.
[6]American Diabetes Association.Standards of medical care in diabetes-2019.Diabetes Care,2019,42(Suppl 1):S184-S186.
[2]Wang H,Naghavi M,Allen C,et al.Global,regional,and national life expectancy,all-cause mortality,and cause-specific mortality for 249 causes of death,1980-2015:A systematic analysis for the global burden of disease study 2015.Lancet,2016,388:1459-1544.
[3]Cao B,Bray F,Ilbawi A,et al.Effect on longevity of onethird reduction in premature mortality from non-communicable diseases by 2030:A global analysis of the sustainable development goal health target.Lancet Glob Health,2018,6:e1288-e1296.
[4]Bragg F,Holmes MV,Iona A,et al.Association between diabetes and cause-specific mortality in rural and urban areas of China.JAMA,2017,317:280-289.
[5]Home P.Cardiovascular outcome trials of glucose-lowering medications:An update.Diabetologia,2019 Jan 3.doi:10.1007/s00125-018-4801-1.
[6]American Diabetes Association.Standards of medical care in diabetes-2019.Diabetes Care,2019,42(Suppl 1):S184-S186.